{"id":2300,"date":"2020-06-08T13:51:14","date_gmt":"2020-06-08T13:51:14","guid":{"rendered":"https:\/\/hosting.uantwerpen.be\/valuedx\/?p=2300"},"modified":"2020-09-21T13:32:21","modified_gmt":"2020-09-21T13:32:21","slug":"wp2-gets-ready-for-value-dx-clinical-trials","status":"publish","type":"post","link":"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/","title":{"rendered":"VALUE-Dx gets ready for clinical trials"},"content":{"rendered":"\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-jzkylawd-ba86e75d702405f62001a756eb35483d\">\n.avia-section.av-jzkylawd-ba86e75d702405f62001a756eb35483d{\nbackground-color:#08b4a0;\nbackground-image:unset;\n}\n<\/style>\n<div id='av_section_1'  class='avia-section av-jzkylawd-ba86e75d702405f62001a756eb35483d main_color avia-section-default avia-no-border-styling  avia-builder-el-0  el_before_av_section  avia-builder-el-first  avia-bg-style-parallax container_wrap fullsize'  ><div class='container av-section-cont-open' ><main  role=\"main\" itemprop=\"mainContentOfPage\"  class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-2300'><div class='entry-content-wrapper clearfix'>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-kc36bewb-6822e2f538ef8ba491b92a5c6a9e185c\">\n#top .av-special-heading.av-kc36bewb-6822e2f538ef8ba491b92a5c6a9e185c{\npadding-bottom:10px;\n}\nbody .av-special-heading.av-kc36bewb-6822e2f538ef8ba491b92a5c6a9e185c .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-kc36bewb-6822e2f538ef8ba491b92a5c6a9e185c .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-kc36bewb-6822e2f538ef8ba491b92a5c6a9e185c av-special-heading-h3 blockquote modern-quote modern-centered  avia-builder-el-1  el_before_av_codeblock  avia-builder-el-first '><h3 class='av-special-heading-tag '  itemprop=\"headline\"  >VALUE-Dx gets ready for clinical trials<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div>\n\n\n<\/div><\/div><\/main><!-- close content main element --><\/div><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-1cjng-9db903d36b325f87b66fb9ba7e96614e\">\n.avia-section.av-1cjng-9db903d36b325f87b66fb9ba7e96614e{\nbackground-color:#1b7ca4;\nbackground-image:unset;\n}\n<\/style>\n<div id='av_section_2'  class='avia-section av-1cjng-9db903d36b325f87b66fb9ba7e96614e main_color avia-section-default avia-no-border-styling  avia-builder-el-3  el_after_av_section  el_before_av_section  avia-bg-style-scroll container_wrap fullsize'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-2300'><div class='entry-content-wrapper clearfix'>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-k0i4yzrj-318dd765ad6f41d2fe86b741f8548ed0\">\n.flex_column.av-k0i4yzrj-318dd765ad6f41d2fe86b741f8548ed0{\nborder-radius:0px 0px 0px 0px;\npadding:50px 5% 50px 5%;\n}\n<\/style>\n<div  class='flex_column av-k0i4yzrj-318dd765ad6f41d2fe86b741f8548ed0 av_one_full  avia-builder-el-4  el_before_av_one_fifth  avia-builder-el-first  first flex_column_div  '     ><section  class='av_textblock_section av-yfjs-a24130328363a5d48e40d9c86a7bb2c6 '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock'  itemprop=\"text\" ><p>WP2 encompasses <strong>microbiology work<\/strong> performed on clinical samples obtained from WP4 clinical trials, as well as <strong>biobanking<\/strong>. As the clinical trials have not started yet, no actionable results have been obtained so far. However, the WP2 team has been working on the <strong>optimization<\/strong> of the methods to be used once the samples are received.<\/p>\n<p>Specifically, work has been performed on the aetiology elucidation from clinical samples based on next generation sequencing (NGS) techniques. Especial focus has been put into the detection of <em>Streptococcus pneumoniae<\/em> from clinical samples as one of the primary pathogens causing CA-ARTI, but other pathogens, such as viruses, will also be detected. Furthermore, work has been performed on direct detection of antimicrobial resistance (<strong>AMR<\/strong>) in bacterial pathogens by correlating phenotypic and genotypic data. This will allow to predict AMR directly from raw sequencing data.<\/p>\n<p>The WP2 team has collected publicly available and in-house generated <em>S. pneumoniae<\/em> WGS sequences and built a Hidden Markov Model (HMM) based serotyping database for <em>S. pneumoniae<\/em>. This in-house developed database will be used along with phenotypic data, which will enable us to delineate and identify the serotypes, especially novel serotypes, from metagenomics data. This database, the first of its kind for <em>S. pneumoniae<\/em>, will be made publicly available in the near future.<\/p>\n<p>All these methods will be applied in the metagenomics study, which allows defining the microbial community present in a sample, as well as studying the resistome, that is the whole set of antimicrobial resistance genes present in that sample. The clinical trial has not started yet, but the optimization of this protocol is ongoing. The protocol to perform shotgun metagenomics on a short-read sequencing platform (Illumina MiSeq) is optimized, while the protocol for long-read 16S sequencing (PacBio Sequel) is almost complete.<\/p>\n<p>Additionally, work is undergoing for the development of the <strong>bioinformatics pipeline<\/strong> to be used to remove host DNA and analyze the sequencing results. This pipeline includes a first step to removing host reads, and then several analyses are performed (assembly of the metagenome, detection of antimicrobial resistance genes and virulence factors, the taxonomic classification of the bacterial community).<\/p>\n<p>Biomarker detection will proceed by mesoscale discovery (MSD) wherein the instrument is available and the protocols are being optimized. Research will begin when clinical samples are received.<\/p>\n<p>Biobanking will be the next step.<\/p>\n<\/div><\/section><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-3b8mw-b506a38e8d00a7f4906eea669cebc6be\">\n.flex_column.av-3b8mw-b506a38e8d00a7f4906eea669cebc6be{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-3b8mw-b506a38e8d00a7f4906eea669cebc6be av_one_fifth  avia-builder-el-6  el_after_av_one_full  el_before_av_one_fifth  first flex_column_div av-zero-column-padding  column-top-margin'     ><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-2lzlw-3d25ff9ce16d4f57844d3b5b4e0627c5\">\n.flex_column.av-2lzlw-3d25ff9ce16d4f57844d3b5b4e0627c5{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-2lzlw-3d25ff9ce16d4f57844d3b5b4e0627c5 av_one_fifth  avia-builder-el-7  el_after_av_one_fifth  el_before_av_one_fifth  flex_column_div av-zero-column-padding  column-top-margin'     ><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-7tlo-f8416bb2afc61a4a130355b19410e269\">\n.flex_column.av-7tlo-f8416bb2afc61a4a130355b19410e269{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-7tlo-f8416bb2afc61a4a130355b19410e269 av_one_fifth  avia-builder-el-8  el_after_av_one_fifth  el_before_av_one_fifth  flex_column_div av-zero-column-padding  column-top-margin'     ><div  class='av-social-sharing-box av-k0i4kjks-6d3450111d8e25130dca06d4190760bd av-social-sharing-box-minimal  avia-builder-el-9  avia-builder-el-no-sibling  av-social-sharing-box-fullwidth'><div class=\"av-share-box\"><ul class=\"av-share-box-list noLightbox\"><li class='av-share-link av-social-link-twitter avia_social_iconfont' ><a target=\"_blank\" aria-label=\"Share on X\" href='https:\/\/twitter.com\/share?text=VALUE-Dx%20gets%20ready%20for%20clinical%20trials&#038;url=https:\/\/www.value-dx.eu\/?p=2300' data-av_icon='\ue932' data-av_iconfont='entypo-fontello'  title='' data-avia-related-tooltip='Share on X'><span class='avia_hidden_link_text'>Share on X<\/span><\/a><\/li><li class='av-share-link av-social-link-linkedin avia_social_iconfont' ><a target=\"_blank\" aria-label=\"Share on LinkedIn\" href='https:\/\/linkedin.com\/shareArticle?mini=true&#038;title=VALUE-Dx%20gets%20ready%20for%20clinical%20trials&#038;url=https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/' data-av_icon='\ue8fc' data-av_iconfont='entypo-fontello'  title='' data-avia-related-tooltip='Share on LinkedIn'><span class='avia_hidden_link_text'>Share on LinkedIn<\/span><\/a><\/li><li class='av-share-link av-social-link-mail avia_social_iconfont' ><a  aria-label=\"Share by Mail\" href='mailto:?subject=VALUE-Dx%20gets%20ready%20for%20clinical%20trials&#038;body=https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/' data-av_icon='\ue805' data-av_iconfont='entypo-fontello'  title='' data-avia-related-tooltip='Share by Mail'><span class='avia_hidden_link_text'>Share by Mail<\/span><\/a><\/li><\/ul><\/div><\/div><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-1gk3g-e035d72a73a93486e640208771f4a074\">\n.flex_column.av-1gk3g-e035d72a73a93486e640208771f4a074{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-1gk3g-e035d72a73a93486e640208771f4a074 av_one_fifth  avia-builder-el-10  el_after_av_one_fifth  el_before_av_one_fifth  flex_column_div av-zero-column-padding  column-top-margin'     ><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-yzdo-63e3a9df4e270ed0fd52b6929706fb26\">\n.flex_column.av-yzdo-63e3a9df4e270ed0fd52b6929706fb26{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-yzdo-63e3a9df4e270ed0fd52b6929706fb26 av_one_fifth  avia-builder-el-11  el_after_av_one_fifth  avia-builder-el-last  flex_column_div av-zero-column-padding  column-top-margin'     ><\/div>\n\n<\/div><\/div><\/div><!-- close content main div --><\/div><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-k0i590fy-427634ed8909a6d2106239c938ad0962\">\n.avia-section.av-k0i590fy-427634ed8909a6d2106239c938ad0962{\nbackground-color:#1b7ca4;\nbackground-image:unset;\n}\n<\/style>\n<div id='av_section_3'  class='avia-section av-k0i590fy-427634ed8909a6d2106239c938ad0962 main_color avia-section-default avia-no-border-styling  avia-builder-el-12  el_after_av_section  el_before_av_codeblock  avia-bg-style-scroll container_wrap fullsize'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-2300'><div class='entry-content-wrapper clearfix'>\n\n<\/div><\/div><\/div><!-- close content main div --><\/div><\/div><div id='after_section_3'  class='main_color av_default_container_wrap container_wrap fullsize'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-2300'><div class='entry-content-wrapper clearfix'>\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":152,"featured_media":808,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-2300","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VALUE-Dx gets ready for clinical trials - value-dx<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VALUE-Dx gets ready for clinical trials - value-dx\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"value-dx\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-08T13:51:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-09-21T13:32:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2019\/09\/VALUE-Dx_logo_white4.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1226\" \/>\n\t<meta property=\"og:image:height\" content=\"428\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Leandra\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ValueDx\" \/>\n<meta name=\"twitter:site\" content=\"@ValueDx\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Leandra\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2020\\\/06\\\/08\\\/wp2-gets-ready-for-value-dx-clinical-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2020\\\/06\\\/08\\\/wp2-gets-ready-for-value-dx-clinical-trials\\\/\"},\"author\":{\"name\":\"Leandra\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/#\\\/schema\\\/person\\\/9da693a7844518fa62482abe916eba8d\"},\"headline\":\"VALUE-Dx gets ready for clinical trials\",\"datePublished\":\"2020-06-08T13:51:14+00:00\",\"dateModified\":\"2020-09-21T13:32:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2020\\\/06\\\/08\\\/wp2-gets-ready-for-value-dx-clinical-trials\\\/\"},\"wordCount\":1334,\"image\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2020\\\/06\\\/08\\\/wp2-gets-ready-for-value-dx-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.value-dx.eu\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/VALUE-Dx_logo_white4.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2020\\\/06\\\/08\\\/wp2-gets-ready-for-value-dx-clinical-trials\\\/\",\"url\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2020\\\/06\\\/08\\\/wp2-gets-ready-for-value-dx-clinical-trials\\\/\",\"name\":\"VALUE-Dx gets ready for clinical trials - value-dx\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2020\\\/06\\\/08\\\/wp2-gets-ready-for-value-dx-clinical-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2020\\\/06\\\/08\\\/wp2-gets-ready-for-value-dx-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.value-dx.eu\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/VALUE-Dx_logo_white4.png\",\"datePublished\":\"2020-06-08T13:51:14+00:00\",\"dateModified\":\"2020-09-21T13:32:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/#\\\/schema\\\/person\\\/9da693a7844518fa62482abe916eba8d\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2020\\\/06\\\/08\\\/wp2-gets-ready-for-value-dx-clinical-trials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2020\\\/06\\\/08\\\/wp2-gets-ready-for-value-dx-clinical-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2020\\\/06\\\/08\\\/wp2-gets-ready-for-value-dx-clinical-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.value-dx.eu\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/VALUE-Dx_logo_white4.png\",\"contentUrl\":\"https:\\\/\\\/www.value-dx.eu\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/VALUE-Dx_logo_white4.png\",\"width\":1226,\"height\":428},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/2020\\\/06\\\/08\\\/wp2-gets-ready-for-value-dx-clinical-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/homepage\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VALUE-Dx gets ready for clinical trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.value-dx.eu\\\/\",\"name\":\"value-dx\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.value-dx.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.value-dx.eu\\\/#\\\/schema\\\/person\\\/9da693a7844518fa62482abe916eba8d\",\"name\":\"Leandra\",\"url\":\"https:\\\/\\\/www.value-dx.eu\\\/index.php\\\/author\\\/leandra\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VALUE-Dx gets ready for clinical trials - value-dx","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/","og_locale":"en_US","og_type":"article","og_title":"VALUE-Dx gets ready for clinical trials - value-dx","og_url":"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/","og_site_name":"value-dx","article_published_time":"2020-06-08T13:51:14+00:00","article_modified_time":"2020-09-21T13:32:21+00:00","og_image":[{"width":1226,"height":428,"url":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2019\/09\/VALUE-Dx_logo_white4.png","type":"image\/png"}],"author":"Leandra","twitter_card":"summary_large_image","twitter_creator":"@ValueDx","twitter_site":"@ValueDx","twitter_misc":{"Written by":"Leandra","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/"},"author":{"name":"Leandra","@id":"https:\/\/www.value-dx.eu\/#\/schema\/person\/9da693a7844518fa62482abe916eba8d"},"headline":"VALUE-Dx gets ready for clinical trials","datePublished":"2020-06-08T13:51:14+00:00","dateModified":"2020-09-21T13:32:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/"},"wordCount":1334,"image":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2019\/09\/VALUE-Dx_logo_white4.png","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/","url":"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/","name":"VALUE-Dx gets ready for clinical trials - value-dx","isPartOf":{"@id":"https:\/\/www.value-dx.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2019\/09\/VALUE-Dx_logo_white4.png","datePublished":"2020-06-08T13:51:14+00:00","dateModified":"2020-09-21T13:32:21+00:00","author":{"@id":"https:\/\/www.value-dx.eu\/#\/schema\/person\/9da693a7844518fa62482abe916eba8d"},"breadcrumb":{"@id":"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/#primaryimage","url":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2019\/09\/VALUE-Dx_logo_white4.png","contentUrl":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2019\/09\/VALUE-Dx_logo_white4.png","width":1226,"height":428},{"@type":"BreadcrumbList","@id":"https:\/\/www.value-dx.eu\/index.php\/2020\/06\/08\/wp2-gets-ready-for-value-dx-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.value-dx.eu\/index.php\/homepage\/"},{"@type":"ListItem","position":2,"name":"VALUE-Dx gets ready for clinical trials"}]},{"@type":"WebSite","@id":"https:\/\/www.value-dx.eu\/#website","url":"https:\/\/www.value-dx.eu\/","name":"value-dx","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.value-dx.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.value-dx.eu\/#\/schema\/person\/9da693a7844518fa62482abe916eba8d","name":"Leandra","url":"https:\/\/www.value-dx.eu\/index.php\/author\/leandra\/"}]}},"jetpack_featured_media_url":"https:\/\/www.value-dx.eu\/wp-content\/uploads\/2019\/09\/VALUE-Dx_logo_white4.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/posts\/2300","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/users\/152"}],"replies":[{"embeddable":true,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/comments?post=2300"}],"version-history":[{"count":0,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/posts\/2300\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/media\/808"}],"wp:attachment":[{"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/media?parent=2300"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/categories?post=2300"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.value-dx.eu\/index.php\/wp-json\/wp\/v2\/tags?post=2300"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}